Artificial intelligence can be used to turn a continuous glucose monitor (CGM) into a potent tool for diabetes monitoring and prevention, suggests researchers at Klick Applied Sciences
Drug firm AstraZeneca India said it has received approval from the country's drug regulator to market anti-diabetes medication Dapagliflozin
Women of South Asian origin may be more likely to experience gestational diabetes due to the same complex genetics that increases their chance of acquiring type 2 diabetes, according to a study
Covid can alter a person's genetic makeup which can enhance the proliferation of disease and cause further deterioration in diabetes and associated heart disease, an Indian-origin researcher revealed
Railway Board has given its catering and tourism arm IRCTC the flexibility to customise its menu to include local, regional cuisines as well as food suitable for diabetics, infants, health aficionados
Diabetes is a chronic metabolic disease. If detected late or improperly managed, it can lead to serious and life-threatening damage to the heart, blood vessels, eyes, kidneys and nerves
On World Diabetes Day, Business Standard spoke with experts to demystify sugar substitutes that have found a way into our diet
In the United States, more than 37 million individuals have diabetes, yet many of them don't receive immediate treatment, which can result in expensive or even fatal consequences
Scientists have uncovered details of the metabolism of late-night eating associated with weight gain and diabetes, according to a study
Around 500 mn people will develop heart disease, obesity, diabetes or other non-communicable diseases (NCDs) due to physical inactivity, WHO's 'Global Status Report on Physical Activity 2022' says
A new bandage treatment, known as a scaffold, to treat diabetic foot ulcers, which is cost-effective while improving patient outcomes, has been designed by researchers at Queen's University Belfast
Children and adolescents infected with COVID-19 show a substantially higher risk of developing type 1 diabetes (T1D), according to a study of over 1 million patients aged 18 and younger
By 2040, Type 1 diabetes cases to increase by 116% in India, says Lancet study
The estimates were tested for accuracy against real world prevalence data from 15 countries
At present, over 1,600 medicines and 250 surgical devices are available in these kendras, which also sells Suvidha Sanitary pads priced at Re 1 per pad
New research states that blood sugar level should be lower than 53 mmol/mol (7%) to avoid health complications
T2D is a chronic and progressive condition in which the body does not make or use insulin normally, leading to high levels of glucose in the blood
Research led by Caroline Crowther of the University of Auckland, New Zealand, and a team, the findings were published in the journal PLOS Medicine
Regulator looking to cap prices of Sitagliptin, Linagliptin and combinations
Zydus Lifesciences Ltd on Friday said it has launched the generic version of sitagliptin in India under the brand names Sitaglyn and Siglyn to address type 2 diabetes.